Clinical Trial Update: Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating safety and efficacy of tradipitant vs placebo in idiopathic and diabetic gastroparesis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis
• Idiopathic Gastroparesis

Drugs mentioned

• Tradipitant (tradipitant)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Idiopathic Gastroparesis, Diabetic Gastroparesis | Phase 3 | Status: COMPLETED